JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an ...
We are thrilled to welcome Matt to our leadership team,” said Allan Reine, M.D., Chief Executive Officer of Prime Medicine. “Business development has been – and will continue to be – a core pillar of ...
In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced achievement of ...
About Prime Medicine Prime Medicine is a leading biotechnology company dedicated ... or clinical studies not being predictive of future results in connection with future studies; the scope of ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...
The Korea Trade-Investment Promotion Agency (KOTRA) announced on the 31st that it had newly signed a Memorandum of ...
As artificial intelligence (AI) becomes a fixture across a broad range of technological fields, AI technology continues to evolve at rapid rates.
The Abu Dhabi Chamber of Commerce and Industry has signed a Memorandum of Understanding (MoU) with Cassa Depositi e Prestiti ...
Poland partnership between AGH University and GGSIPU, uniting tradition and innovation for joint research, sustainable tech, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback